Go Pro

Xerox (XRX) Financials

Xerox logo
$2.80 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$2.89 +0.09 (+3.25%)
As of 07/2/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Xerox

Annual Income Statements for Xerox

This table shows Xerox's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
195 361 3,528 192 -469 -336 -13 -1,335 -1,043
Consolidated Net Income / (Loss)
207 374 1,361 192 -455 -322 1.00 -1,321 -1,029
Net Income / (Loss) Continuing Operations
70 310 651 192 -455 -322 1.00 -1,321 -1,029
Total Pre-Tax Income
525 549 822 252 -472 -325 -28 -1,216 -488
Total Operating Income
525 549 1,728 252 -472 -325 -28 -1,216 -488
Total Gross Profit
4,071 3,869 12,716 2,626 2,514 2,426 2,314 1,960 1,901
Total Revenue
9,991 9,662 18,132 7,022 7,038 7,107 6,886 6,221 7,022
Operating Revenue
9,991 9,662 18,132 7,022 7,038 7,107 6,886 6,221 7,022
Total Cost of Revenue
5,920 5,793 5,416 4,396 4,524 4,681 4,572 4,261 5,121
Operating Cost of Revenue
5,920 5,793 5,416 4,396 4,524 4,681 4,572 4,261 5,121
Total Operating Expenses
3,546 3,320 10,988 2,374 2,986 2,751 2,342 3,176 2,389
Selling, General & Admin Expense
2,514 2,379 2,458 1,851 1,718 1,760 1,696 1,537 1,654
Research & Development Expense
424 397 - 311 310 304 229 191 230
Amortization Expense
53 48 45 56 55 42 43 73 83
Other Operating Expenses / (Income)
339 339 8,256 63 84 168 207 205 356
Impairment Charge
- - 0.00 0.00 781 412 0.00 1,058 0.00
Restructuring Charge
216 157 229 93 38 65 167 112 66
Total Other Income / (Expense), net
0.00 0.00 -84 0.00 0.00 0.00 0.00 0.00 0.00
Income Tax Expense
468 247 179 64 -17 -3.00 -29 105 541
Preferred Stock Dividends Declared
- - - - 14 14 14 14 14
Basic Earnings per Share
$0.71 $1.40 $8.89 $0.85 ($2.56) ($2.15) ($0.09) ($10.75) ($8.25)
Weighted Average Basic Shares Outstanding
- - 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M 128.62M
Diluted Earnings per Share
$0.71 $1.38 $5.80 $0.84 ($2.56) ($2.15) ($0.09) ($10.75) ($8.25)
Weighted Average Diluted Shares Outstanding
- - 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M 128.62M
Weighted Average Basic & Diluted Shares Outstanding
- - 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M 128.62M
Cash Dividends to Common per Share
- $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $0.20

Quarterly Income Statements for Xerox

This table shows Xerox's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
45 -61 -117 15 -1,209 -24 -94 -109 -764 -76 -109
Consolidated Net Income / (Loss)
49 -58 -113 18 -1,205 -21 -90 -106 -760 -73 -105
Net Income / (Loss) Continuing Operations
49 -58 -113 18 -1,205 -21 -90 -106 -760 -73 -105
Total Pre-Tax Income
64 -88 -150 25 -1,087 -4.00 -67 -60 -300 -61 -73
Total Operating Income
64 -88 -150 25 -1,087 -4.00 -67 -60 -300 -61 -73
Total Gross Profit
566 528 443 520 495 579 426 451 445 579 549
Total Revenue
1,652 1,765 1,502 1,578 1,528 1,613 1,457 1,576 1,961 2,028 1,846
Operating Revenue
1,652 1,765 1,502 1,578 1,528 1,613 1,457 1,576 1,961 2,028 1,846
Total Cost of Revenue
1,086 1,237 1,059 1,058 1,033 1,034 1,031 1,125 1,516 1,449 1,297
Operating Cost of Revenue
1,086 1,237 1,059 1,058 1,033 1,034 1,031 1,125 1,516 1,449 1,297
Total Operating Expenses
502 616 593 495 1,582 583 493 511 745 640 622
Selling, General & Admin Expense
416 440 397 393 370 377 378 368 477 431 430
Research & Development Expense
52 56 49 50 45 47 42 43 74 71 64
Amortization Expense
12 10 10 10 10 43 10 10 30 33 30
Other Operating Expenses / (Income)
12 -22 98 30 43 111 64 80 105 107 53
Restructuring Charge
10 132 39 12 56 5.00 -1.00 10 59 -2.00 45
Total Other Income / (Expense), net
0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Income Tax Expense
15 -30 -37 7.00 118 17 23 46 460 12 32
Preferred Stock Dividends Declared
4.00 3.00 4.00 3.00 4.00 3.00 4.00 3.00 4.00 3.00 4.00
Basic Earnings per Share
$0.29 ($0.40) ($0.94) $0.12 ($9.71) ($0.22) ($0.75) ($0.87) ($6.01) ($0.62) ($0.84)
Weighted Average Basic Shares Outstanding
122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M 125.83M 128.04M 128.62M 130.78M
Diluted Earnings per Share
$0.28 ($0.39) ($0.94) $0.11 ($9.71) ($0.21) ($0.75) ($0.87) ($6.01) ($0.62) ($0.84)
Weighted Average Diluted Shares Outstanding
122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M 125.83M 128.04M 128.62M 130.78M
Weighted Average Basic & Diluted Shares Outstanding
122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M 125.83M 128.04M 128.62M 130.78M
Cash Dividends to Common per Share
$0.25 - $0.25 $0.25 $0.25 - $0.13 $0.03 $0.03 - $0.03

Annual Cash Flow Statements for Xerox

This table details how cash moves in and out of Xerox's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-2,041 -2.00 1,647 -104 -782 -770 -522 14 -66
Net Cash From Operating Activities
-534 2,280 1,333 548 629 159 686 511 224
Net Cash From Continuing Operating Activities
-498 2,164 1,244 548 629 159 686 511 224
Net Income / (Loss) Continuing Operations
140 620 651 192 -455 -322 1.00 -1,321 -1,029
Consolidated Net Income / (Loss)
414 748 1,361 192 -455 -322 1.00 -1,321 -1,029
Depreciation Expense
1,054 1,052 430 368 327 270 251 274 331
Non-Cash Adjustments To Reconcile Net Income
1,002 846 533 53 619 422 264 1,281 164
Changes in Operating Assets and Liabilities, net
-2,260 142 12 -65 138 -211 170 277 758
Net Cash From Investing Activities
330 -58 2,148 -246 -85 -78 -5.00 -198 -698
Net Cash From Continuing Investing Activities
330 -58 -85 -246 -85 -78 -5.00 -198 -698
Purchase of Property, Plant & Equipment
-210 -180 65 -74 -68 -57 -37 -44 -91
Acquisitions
-174 0.00 42 -203 -53 -93 -7.00 -161 -674
Divestitures
- - - 30 44 87 43 35 79
Other Investing Activities, net
413 4.00 20 1.00 -8.00 -15 -4.00 -28 -12
Net Cash From Financing Activities
-1,970 -2,602 -1,834 -416 -1,310 -822 -1,202 -271 404
Net Cash From Continuing Financing Activities
-1,970 -2,602 -1,834 -416 -1,310 -822 -1,202 -271 404
Repayment of Debt
-3,408 -672 919 -2,245 -527 -1,729 -1,889 -1,006 -665
Repurchase of Common Equity
0.00 -1,400 600 -300 -888 -113 -544 -8.00 0.00
Payment of Dividends
-582 -538 243 -230 -206 -174 -165 -141 -71
Issuance of Debt
2,020 8.00 10 2,359 311 1,194 1,396 907 1,140
Other Financing Activities, net
- 0.00 - - - 0.00 0.00 -23 0.00
Effect of Exchange Rate Changes
- - - 10 -16 -29 -1.00 -28 4.00

Quarterly Cash Flow Statements for Xerox

This table details how cash moves in and out of Xerox's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
48 - 155 -221 39 41 -241 595 -450 30 72
Net Cash From Operating Activities
124 389 -79 123 116 351 -89 -11 116 208 -144
Net Cash From Continuing Operating Activities
124 389 -79 123 116 351 -89 -11 116 208 -144
Net Income / (Loss) Continuing Operations
49 -58 -113 18 -1,205 -21 -90 -106 -760 -73 -105
Consolidated Net Income / (Loss)
49 -58 -113 18 -1,205 -21 -90 -106 -760 -73 -105
Depreciation Expense
63 62 59 59 59 97 60 57 107 107 100
Non-Cash Adjustments To Reconcile Net Income
-35 128 146 37 1,093 5.00 6.00 39 107 12 2.00
Changes in Operating Assets and Liabilities, net
47 257 -171 9.00 169 270 -65 -1.00 662 162 -141
Net Cash From Investing Activities
25 -8.00 -17 -2.00 -7.00 -172 6.00 -18 -682 -4.00 -24
Net Cash From Continuing Investing Activities
25 -8.00 -17 -2.00 -7.00 -172 6.00 -18 -682 -4.00 -24
Purchase of Property, Plant & Equipment
-12 -10 -10 -8.00 -9.00 -17 -20 -19 -28 -24 -21
Acquisitions
- - 0.00 - - -161 1.00 - -675 - 0.00
Divestitures
37 3.00 4.00 15 8.00 8.00 27 3.00 26 23 2.00
Other Investing Activities, net
- -1.00 -11 -9.00 -6.00 -2.00 -2.00 -2.00 -5.00 -3.00 -5.00
Net Cash From Financing Activities
-94 -383 261 -336 -74 -122 -159 618 118 -173 242
Net Cash From Continuing Financing Activities
-94 -383 261 -336 -74 -122 -159 618 118 -173 242
Repayment of Debt
-373 -879 -581 -303 -38 -84 -123 -249 -123 -170 -194
Payment of Dividends
-43 -34 -37 -34 -36 -34 -39 -19 -7.00 -6.00 -10
Issuance of Debt
866 530 905 1.00 - 1.00 3.00 886 248 3.00 446
Effect of Exchange Rate Changes
-7.00 2.00 -10 -6.00 4.00 -16 1.00 6.00 -2.00 -1.00 -2.00

Annual Balance Sheets for Xerox

This table presents Xerox's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
29,748 30,094 14,741 13,223 11,543 10,008 8,365 9,823
Total Current Assets
9,426 12,280 5,783 4,701 4,107 3,177 2,935 3,568
Cash & Equivalents
2,162 5,480 2,625 1,840 1,045 519 576 512
Note & Lease Receivable
2,646 2,538 1,181 1,136 1,154 913 656 556
Accounts Receivable
2,540 2,472 883 818 857 850 796 1,122
Inventories, net
1,658 1,388 843 696 797 661 695 1,016
Other Current Assets
382 402 251 211 254 234 212 362
Plant, Property, & Equipment, net
1,880 0.00 407 358 320 266 251 390
Plant, Property & Equipment, gross
- - 407 358 320 266 251 390
Total Noncurrent Assets
18,442 16,234 8,551 8,164 7,116 6,565 5,179 5,865
Noncurrent Note & Lease Receivables
4,298 4,164 1,984 1,934 1,948 1,597 1,089 846
Goodwill
7,716 7,800 4,071 3,287 2,820 2,747 1,937 2,222
Intangible Assets
440 398 237 211 208 177 236 921
Noncurrent Deferred & Refundable Income Taxes
1,480 1,196 508 519 582 745 615 98
Other Noncurrent Operating Assets
1,804 2,676 1,751 2,213 1,558 1,299 1,302 1,778
Total Liabilities & Shareholders' Equity
29,748 30,094 14,741 13,223 11,543 10,008 8,365 9,823
Total Liabilities
19,242 18,412 8,931 8,556 7,966 7,236 7,061 9,150
Total Current Liabilities
6,502 6,804 2,478 2,829 3,330 2,779 2,619 3,222
Short-Term Debt
1,922 - 394 650 860 567 585 231
Accounts Payable
2,146 2,106 983 1,069 1,331 1,044 1,023 1,498
Accrued Expenses
- - - 871 881 862 784 1,258
Current Employee Benefit Liabilities
696 698 261 239 258 306 227 235
Total Noncurrent Liabilities
12,740 8,375 6,453 5,727 4,636 4,457 4,442 5,928
Long-Term Debt
8,538 3,233 4,050 3,596 2,866 2,710 2,814 4,016
Noncurrent Employee Benefit Liabilities
3,664 4,118 1,906 1,650 1,359 1,387 1,242 1,227
Other Noncurrent Operating Liabilities
538 1,024 497 481 411 360 386 685
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
428 214 214 224 224 224 224 224
Total Equity & Noncontrolling Interests
10,078 11,468 5,596 4,443 3,353 2,548 1,080 449
Total Preferred & Common Equity
10,010 11,454 5,592 4,436 3,343 2,538 1,076 444
Total Common Equity
10,010 11,454 5,592 4,436 3,343 2,538 1,076 444
Common Stock
7,106 6,263 2,643 1,970 1,744 1,237 1,261 1,311
Retained Earnings
10,144 12,559 6,281 5,631 5,136 4,977 3,514 2,444
Accumulated Other Comprehensive Income / (Loss)
-7,130 -7,292 -3,332 -2,988 -3,537 -3,676 -3,699 -3,311
Noncontrolling Interest
68 14 4.00 7.00 10 10 4.00 5.00

Quarterly Balance Sheets for Xerox

This table presents Xerox's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
11,420 11,046 10,569 10,444 9,944 9,491 8,322 8,211 8,874 10,068 9,902
Total Current Assets
3,895 3,640 3,390 3,354 3,348 3,051 3,011 2,867 3,543 3,753 3,780
Cash & Equivalents
932 591 477 532 685 485 521 336 449 479 585
Note & Lease Receivable
1,086 1,116 1,010 986 850 783 714 626 630 606 519
Accounts Receivable
835 818 903 880 846 847 821 819 862 1,196 1,218
Inventories, net
777 863 782 728 736 737 732 836 871 1,143 1,043
Other Current Assets
265 252 218 228 231 199 223 250 731 329 415
Plant, Property, & Equipment, net
315 311 281 273 245 227 225 195 187 427 378
Plant, Property & Equipment, gross
315 311 281 273 245 227 225 195 187 427 378
Total Noncurrent Assets
7,210 7,095 6,898 6,817 6,351 6,213 5,086 5,149 5,144 5,888 5,744
Noncurrent Note & Lease Receivables
1,814 1,864 1,697 1,605 1,408 1,277 1,275 1,013 990 950 797
Goodwill
2,753 2,850 2,751 2,716 2,720 2,719 1,709 1,954 1,984 2,182 2,201
Intangible Assets
216 202 194 183 165 155 149 228 222 954 891
Noncurrent Deferred & Refundable Income Taxes
496 598 620 701 749 760 635 607 551 101 96
Other Noncurrent Operating Assets
1,931 1,581 1,636 1,612 1,309 1,302 1,318 1,347 1,397 1,701 1,759
Total Liabilities & Shareholders' Equity
11,420 11,046 10,569 10,444 9,944 9,491 8,322 8,211 8,874 10,068 9,902
Total Liabilities
7,942 7,355 6,953 7,422 7,339 6,902 6,791 6,930 7,523 9,474 9,373
Total Current Liabilities
3,343 2,879 2,949 3,006 2,438 2,046 2,393 2,639 2,426 3,399 3,202
Short-Term Debt
1,070 553 891 870 405 129 519 599 458 354 165
Accounts Payable
1,213 1,301 1,041 1,031 1,046 936 895 1,120 1,080 1,481 1,548
Accrued Expenses
810 782 766 829 774 776 752 721 706 1,317 1,266
Current Employee Benefit Liabilities
250 243 251 276 213 205 227 199 182 247 223
Total Noncurrent Liabilities
4,599 4,476 4,004 4,416 4,901 4,856 4,398 4,291 5,097 6,075 6,171
Long-Term Debt
2,676 2,726 2,225 2,739 3,199 3,174 2,752 2,699 3,484 4,052 4,281
Noncurrent Employee Benefit Liabilities
1,507 1,350 1,385 1,306 1,350 1,344 1,292 1,229 1,236 1,318 1,193
Other Noncurrent Operating Liabilities
416 400 394 371 352 338 354 363 377 705 697
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
224 224 224 224 214 224 224 224 224 224 224
Total Equity & Noncontrolling Interests
3,254 3,467 3,392 2,798 2,381 2,365 1,307 1,057 1,127 370 305
Total Preferred & Common Equity
3,243 3,459 3,384 2,789 2,378 2,361 1,303 1,053 1,122 365 299
Total Common Equity
3,243 3,459 3,384 2,789 2,378 2,361 1,303 1,053 1,122 365 299
Common Stock
1,733 1,751 1,764 1,776 1,223 1,238 1,247 1,267 1,280 1,299 1,323
Retained Earnings
5,057 5,162 5,057 5,070 4,828 4,810 3,570 3,403 3,290 2,523 2,320
Accumulated Other Comprehensive Income / (Loss)
-3,547 -3,454 -3,437 -3,504 -3,673 -3,687 -3,514 -3,617 -3,448 -3,457 -3,344
Noncontrolling Interest
11 8.00 8.00 9.00 3.00 4.00 4.00 4.00 5.00 5.00 6.00

Annual Metrics And Ratios for Xerox

This table displays calculated financial ratios and metrics derived from Xerox's official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - 128,040,011.00
DEI Adjusted Shares Outstanding
- - - - - - - - 128,040,011.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - -8.15
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% -3.29% 87.66% -61.27% 0.23% 0.98% -3.11% -9.66% 12.88%
EBITDA Growth
0.00% 1.39% 29.54% -70.11% -123.39% 62.07% 505.45% -522.42% 83.33%
EBIT Growth
0.00% 4.57% 199.45% -84.67% -287.30% 31.14% 91.38% -4,242.86% 59.87%
NOPAT Growth
0.00% 429.82% 347.59% -86.09% -275.74% 31.14% 91.38% -4,242.86% 59.87%
Net Income Growth
0.00% 80.68% 263.90% -85.89% -336.98% 29.23% 100.31% -132,200.00% 22.10%
EPS Growth
0.00% 94.37% 320.29% -85.52% -404.76% 16.02% 95.81% -11,844.44% 23.26%
Operating Cash Flow Growth
0.00% 526.97% -41.54% -58.89% 14.78% -74.72% 331.45% -25.51% -56.16%
Free Cash Flow Firm Growth
0.00% 0.00% 127.02% 34.55% -96.07% 160.42% 20.58% -22.11% -212.83%
Invested Capital Growth
0.00% 0.00% -18.12% -42.14% -7.29% -11.52% -11.63% -25.37% 6.81%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -57.70% -2.13% 2.36% -2.49% -2.39% 6.28%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -56.61% -121.20% 93.88% -51.84% 11.22% -42.73%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -81.88% -239.23% 72.50% -113.40% 6.46% -13.23%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -82.57% -213.15% 72.50% -110.65% 6.46% -13.23%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -79.44% -253.72% 71.20% -99.45% 2.72% -5.32%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% -274.15% 67.37% -108.49% 1.65% -5.23%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -49.12% 480.56% -5.56% -7.02% 42.03% -6.92% -38.96%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -96.77% 43.43% 87.90% -39.23% -14.93%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -46.33% -6.06% -0.54% -9.33% -3.60% -2.50%
Profitability Metrics
- - - - - - - - -
Gross Margin
40.75% 40.04% 70.13% 37.40% 35.72% 34.14% 33.60% 33.21% 27.07%
EBITDA Margin
15.80% 16.57% 11.44% 8.83% -2.06% -0.77% 3.24% -15.14% -2.24%
Operating Margin
5.25% 5.68% 9.53% 3.59% -6.71% -4.57% -0.41% -19.55% -6.95%
EBIT Margin
5.25% 5.68% 9.07% 3.59% -6.71% -4.57% -0.41% -19.55% -6.95%
Profit (Net Income) Margin
2.07% 3.87% 7.51% 2.73% -6.46% -4.53% 0.01% -21.23% -14.65%
Tax Burden Percent
39.43% 68.12% 165.57% 76.19% 96.40% 99.08% -3.57% 108.63% 210.86%
Interest Burden Percent
100.00% 100.00% 50.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
89.14% 44.99% 21.78% 25.40% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 3.75% 9.23% 1.81% -4.49% -3.41% -0.33% -17.63% -8.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 6.32% 9.49% 2.05% -10.39% -7.13% 0.43% -34.46% -28.97%
Return on Net Nonoperating Assets (RNNOA)
0.00% 3.37% 3.04% 0.39% -4.19% -4.40% 0.36% -47.19% -96.09%
Return on Equity (ROE)
0.00% 7.12% 12.27% 2.20% -8.69% -7.81% 0.03% -64.82% -104.10%
Cash Return on Invested Capital (CROIC)
0.00% -196.25% 29.15% 55.20% 3.07% 8.81% 12.02% 11.43% -14.59%
Operating Return on Assets (OROA)
0.00% 1.85% 5.49% 1.12% -3.38% -2.62% -0.26% -13.24% -5.37%
Return on Assets (ROA)
0.00% 1.26% 4.55% 0.86% -3.25% -2.60% 0.01% -14.38% -11.32%
Return on Common Equity (ROCE)
0.00% 6.78% 11.87% 2.14% -8.31% -7.37% 0.03% -57.47% -80.03%
Return on Equity Simple (ROE_SIMPLE)
0.00% 3.74% 11.88% 3.43% -10.26% -9.63% 0.04% -122.77% 0.00%
Net Operating Profit after Tax (NOPAT)
57 302 1,352 188 -330 -228 -20 -851 -342
NOPAT Margin
0.57% 3.13% 7.45% 2.68% -4.69% -3.20% -0.28% -13.68% -4.86%
Net Nonoperating Expense Percent (NNEP)
0.00% -2.57% -0.26% -0.24% 5.90% 3.72% -0.76% 16.84% 20.96%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - -3.21% -0.34% -19.00% -7.27%
Cost of Revenue to Revenue
59.25% 59.96% 29.87% 62.60% 64.28% 65.86% 66.40% 66.79% 72.93%
SG&A Expenses to Revenue
25.16% 24.62% 13.56% 26.36% 24.41% 24.76% 24.63% 24.71% 23.55%
R&D to Revenue
4.24% 4.11% 0.00% 4.43% 4.40% 4.28% 3.33% 3.07% 3.28%
Operating Expenses to Revenue
35.49% 34.36% 60.60% 33.81% 42.43% 38.71% 34.01% 52.76% 34.02%
Earnings before Interest and Taxes (EBIT)
525 549 1,644 252 -472 -325 -28 -1,216 -488
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,579 1,601 2,074 620 -145 -55 223 -942 -157
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.54 0.67 0.78 0.58 0.81 0.97 0.67
Price to Tangible Book Value (P/TBV)
0.00 0.00 1.89 2.92 3.67 6.20 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.34 0.53 0.49 0.27 0.30 0.17 0.04
Price to Earnings (P/E)
0.00 0.00 1.74 19.52 0.00 0.00 0.00 0.00 0.00
Dividend Yield
4.77% 6.76% 3.51% 5.29% 5.19% 7.97% 5.95% 11.86% 8.61%
Earnings Yield
0.00% 0.00% 57.36% 5.12% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.31 0.76 0.86 0.78 0.91 0.99 0.97
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.23 0.82 0.86 0.69 0.73 0.66 0.61
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 1.99 9.33 0.00 0.00 22.68 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 2.51 22.95 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 3.06 30.77 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 3.10 10.56 9.66 30.62 7.37 8.02 19.02
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.97 1.01 26.93 8.29 7.14 7.43 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 1.00 0.28 0.76 0.91 1.04 1.18 2.61 6.31
Long-Term Debt to Equity
0.00 0.81 0.28 0.70 0.77 0.80 0.98 2.16 5.97
Financial Leverage
0.00 0.53 0.32 0.19 0.40 0.62 0.86 1.37 3.32
Leverage Ratio
0.00 2.83 2.70 2.56 2.67 3.00 3.39 4.51 9.20
Compound Leverage Factor
0.00 2.83 1.35 2.56 2.67 3.00 3.39 4.51 9.20
Debt to Total Capital
0.00% 49.89% 21.68% 43.34% 47.64% 51.02% 54.17% 72.27% 86.32%
Short-Term Debt to Total Capital
0.00% 9.17% 0.00% 3.84% 7.29% 11.78% 9.37% 12.44% 4.70%
Long-Term Debt to Total Capital
0.00% 40.72% 21.68% 39.50% 40.35% 39.24% 44.80% 59.83% 81.63%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 2.37% 1.53% 2.13% 2.59% 3.20% 3.87% 4.85% 4.65%
Common Equity to Total Capital
0.00% 47.74% 76.80% 54.53% 49.77% 45.78% 41.96% 22.88% 9.02%
Debt to EBITDA
0.00 6.53 1.56 7.17 -29.28 -67.75 14.70 -3.61 -27.05
Net Debt to EBITDA
0.00 5.18 -1.08 2.93 -16.59 -48.75 12.37 -3.00 -23.79
Long-Term Debt to EBITDA
0.00 5.33 1.56 6.53 -24.80 -52.11 12.15 -2.99 -25.58
Debt to NOPAT
0.00 34.64 2.39 23.64 -12.85 -16.38 -167.19 -3.99 -12.43
Net Debt to NOPAT
0.00 27.48 -1.66 9.68 -7.28 -11.78 -140.71 -3.32 -10.93
Long-Term Debt to NOPAT
0.00 28.27 2.39 21.54 -10.88 -12.60 -138.27 -3.31 -11.76
Altman Z-Score
0.00 0.00 1.79 1.65 1.42 1.37 1.59 0.99 0.96
Noncontrolling Interest Sharing Ratio
0.00% 4.72% 3.26% 2.55% 4.29% 5.64% 7.37% 11.33% 23.12%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 1.45 1.80 2.33 1.66 1.23 1.14 1.12 1.11
Quick Ratio
0.00 1.13 1.54 1.89 1.34 0.92 0.82 0.77 0.68
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -15,802 4,270 5,745 226 588 708 552 -623
Operating Cash Flow to CapEx
-254.29% 1,266.67% 0.00% 740.54% 925.00% 278.95% 1,854.05% 1,161.36% 246.15%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 0.32 0.61 0.31 0.50 0.57 0.64 0.68 0.77
Accounts Receivable Turnover
0.00 3.80 7.24 4.19 8.28 8.49 8.07 7.56 7.32
Inventory Turnover
0.00 3.49 3.56 3.94 5.88 6.27 6.27 6.13 5.99
Fixed Asset Turnover
0.00 5.14 0.00 0.00 18.40 20.96 23.50 24.07 21.91
Accounts Payable Turnover
0.00 2.70 2.55 2.85 4.41 3.90 3.85 4.02 4.06
Days Sales Outstanding (DSO)
0.00 95.95 50.45 87.20 44.11 43.01 45.24 48.29 49.85
Days Inventory Outstanding (DIO)
0.00 104.47 102.64 92.62 62.08 58.21 58.20 59.56 60.98
Days Payable Outstanding (DPO)
0.00 135.21 143.28 128.24 82.78 93.57 94.80 90.79 89.84
Cash Conversion Cycle (CCC)
0.00 65.21 9.81 51.58 23.41 7.65 8.64 17.06 20.98
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 16,104 13,186 7,629 7,073 6,258 5,530 4,127 4,408
Invested Capital Turnover
0.00 1.20 1.24 0.67 0.96 1.07 1.17 1.29 1.65
Increase / (Decrease) in Invested Capital
0.00 16,104 -2,918 -5,557 -556 -815 -728 -1,403 281
Enterprise Value (EV)
0.00 0.00 4,132 5,784 6,076 4,868 5,057 4,099 4,262
Market Capitalization
0.00 0.00 6,151 3,747 3,439 1,953 2,065 1,048 298
Book Value per Share
$0.00 $0.00 $52.98 $28.19 $24.85 $21.48 $20.65 $8.65 $3.47
Tangible Book Value per Share
$0.00 $0.00 $15.06 $6.47 $5.25 $2.02 ($3.14) ($8.82) ($21.08)
Total Capital
0.00 20,966 14,915 10,254 8,913 7,303 6,049 4,703 4,920
Total Debt
0.00 10,460 3,233 4,444 4,246 3,726 3,277 3,399 4,247
Total Long-Term Debt
0.00 8,538 3,233 4,050 3,596 2,866 2,710 2,814 4,016
Net Debt
0.00 8,298 -2,247 1,819 2,406 2,681 2,758 2,823 3,735
Capital Expenditures (CapEx)
210 180 -65 74 68 57 37 44 91
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 2,684 -4.00 1,074 682 592 446 325 65
Debt-free Net Working Capital (DFNWC)
0.00 4,846 5,476 3,699 2,522 1,637 965 901 577
Net Working Capital (NWC)
0.00 2,924 5,476 3,305 1,872 777 398 316 346
Net Nonoperating Expense (NNE)
-150 -72 -9.29 -4.00 125 95 -21 470 687
Net Nonoperating Obligations (NNO)
0.00 5,598 1,504 1,819 2,406 2,681 2,758 2,823 3,735
Total Depreciation and Amortization (D&A)
1,054 1,052 430 368 327 270 251 274 331
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 27.78% -0.02% 15.29% 9.69% 8.33% 6.48% 5.22% 0.93%
Debt-free Net Working Capital to Revenue
0.00% 50.16% 30.20% 52.68% 35.83% 23.03% 14.01% 14.48% 8.22%
Net Working Capital to Revenue
0.00% 30.26% 30.20% 47.07% 26.60% 10.93% 5.78% 5.08% 4.93%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.85 ($5.12) ($2.15) ($0.09) ($10.75) ($8.25)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M 128.62M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.84 ($2.56) ($2.15) ($0.09) ($10.75) ($8.25)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M 128.62M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M 128.62M
Normalized Net Operating Profit after Tax (NOPAT)
519 388 1,531 257 243 106 97 -32 -295
Normalized NOPAT Margin
5.19% 4.02% 8.44% 3.67% 3.45% 1.50% 1.41% -0.52% -4.21%
Pre Tax Income Margin
5.25% 5.68% 4.53% 3.59% -6.71% -4.57% -0.41% -19.55% -6.95%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
281.16% 143.85% -17.85% 119.79% -45.27% -54.04% 16,500.00% -10.67% -6.90%
Augmented Payout Ratio
281.16% 518.18% -61.94% 276.04% -240.44% -89.13% 70,900.00% -11.28% -6.90%

Quarterly Metrics And Ratios for Xerox

This table displays calculated financial ratios and metrics derived from Xerox's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - 125,789,546.00 125,829,398.00 128,040,011.00 128,617,804.00
DEI Adjusted Shares Outstanding
- - - - - - - 125,789,546.00 125,829,398.00 128,040,011.00 128,617,804.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - -0.87 -6.07 -0.59 -0.85
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-5.65% -9.07% -12.42% -10.03% -7.51% -8.61% -3.00% -0.13% 28.34% 25.73% 26.70%
EBITDA Growth
140.32% -112.15% -161.07% 411.11% -909.45% 457.69% 92.31% -103.57% 81.23% -50.54% 485.71%
EBIT Growth
116.84% -159.06% -276.47% 128.09% -1,798.44% 95.45% 55.33% -340.00% 72.40% -1,425.00% -8.96%
NOPAT Growth
118.42% -149.28% -247.89% 128.89% -1,652.86% 95.45% 55.33% -333.33% 72.40% -1,425.00% -8.96%
Net Income Growth
112.83% -147.54% -259.15% 129.51% -2,559.18% 63.79% 20.35% -688.89% 36.93% -247.62% -16.67%
EPS Growth
111.29% -151.32% -318.60% 126.83% -3,567.86% 46.15% 20.21% -890.91% 38.11% -195.24% -12.00%
Operating Cash Flow Growth
1,650.00% 109.14% -201.28% 29.47% -6.45% -9.77% -12.66% -108.94% 0.00% -40.74% -61.80%
Free Cash Flow Firm Growth
-75.08% -29.11% 7.91% 69.90% 336.82% 110.11% 64.55% -39.84% -142.57% -123.12% -116.05%
Invested Capital Growth
-3.07% -11.63% -13.40% -13.56% -29.81% -25.37% -23.19% -10.41% 5.61% 6.81% 3.46%
Revenue Q/Q Growth
-5.82% 6.84% -14.90% 5.06% -3.17% 5.56% -9.67% 8.17% 24.43% 3.42% -8.97%
EBITDA Q/Q Growth
570.37% -120.47% -264.00% 192.31% -1,323.81% 109.05% -107.53% 57.14% -6,333.33% 123.83% -41.30%
EBIT Q/Q Growth
171.91% -237.50% -72.41% 116.67% -4,448.00% 99.63% -1,575.00% 10.45% -400.00% 79.67% -19.67%
NOPAT Q/Q Growth
178.65% -225.71% -72.41% 117.14% -4,327.22% 99.63% -1,575.00% 10.45% -400.00% 79.67% -19.67%
Net Income Q/Q Growth
180.33% -218.37% -94.83% 115.93% -6,794.44% 98.26% -328.57% -17.78% -616.98% 90.39% -43.84%
EPS Q/Q Growth
168.29% -239.29% -141.03% 111.70% -8,927.27% 97.84% -257.14% -16.00% -590.80% 89.68% -35.48%
Operating Cash Flow Q/Q Growth
30.53% 213.71% -120.31% 255.70% -5.69% 202.59% -125.36% 87.64% 1,154.55% 79.31% -169.23%
Free Cash Flow Firm Q/Q Growth
-52.52% 175.37% 12.43% 15.47% 22.07% 32.46% -11.86% -57.78% -186.37% 28.07% 38.80%
Invested Capital Q/Q Growth
-2.49% -9.33% -0.11% -2.12% -20.82% -3.60% 2.81% 14.16% -6.67% -2.50% -0.41%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
34.26% 29.92% 29.49% 34.79% 32.40% 35.90% 29.24% 28.62% 22.69% 28.55% 29.74%
EBITDA Margin
7.69% -1.47% -6.06% 5.32% -67.28% 5.77% -0.48% -0.19% -9.84% 2.27% 1.46%
Operating Margin
3.87% -4.99% -9.99% 1.58% -71.14% -0.25% -4.60% -3.81% -15.30% -3.01% -3.95%
EBIT Margin
3.87% -4.99% -9.99% 1.58% -71.14% -0.25% -4.60% -3.81% -15.30% -3.01% -3.95%
Profit (Net Income) Margin
2.97% -3.29% -7.52% 1.14% -78.86% -1.30% -6.18% -6.73% -38.76% -3.60% -5.69%
Tax Burden Percent
76.56% 65.91% 75.33% 72.00% 110.86% 525.00% 134.33% 176.67% 253.33% 119.67% 143.84%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
23.44% 0.00% 0.00% 28.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
3.38% -4.08% -7.84% 1.27% -61.15% -0.22% -4.07% -3.21% -16.08% -3.46% -4.75%
ROIC Less NNEP Spread (ROIC-NNEP)
3.38% -3.95% -8.12% 1.27% -76.39% -0.88% -5.53% -5.24% -32.55% -4.39% -6.33%
Return on Net Nonoperating Assets (RNNOA)
3.06% -3.38% -7.26% 1.12% -97.77% -1.20% -8.41% -8.39% -102.28% -14.56% -23.87%
Return on Equity (ROE)
6.45% -7.46% -15.10% 2.39% -158.91% -1.42% -12.48% -11.60% -118.36% -18.02% -28.62%
Cash Return on Invested Capital (CROIC)
6.09% 12.02% 11.27% 12.75% 17.50% 11.43% 9.99% -5.65% -12.31% -14.59% -11.42%
Operating Return on Assets (OROA)
2.50% -3.19% -6.35% 1.03% -48.32% -0.17% -3.13% -2.56% -10.99% -2.32% -3.24%
Return on Assets (ROA)
1.92% -2.10% -4.78% 0.74% -53.56% -0.88% -4.20% -4.52% -27.85% -2.78% -4.65%
Return on Common Equity (ROCE)
5.98% -6.91% -14.02% 2.21% -142.82% -1.26% -11.05% -10.26% -92.90% -13.86% -21.38%
Return on Equity Simple (ROE_SIMPLE)
6.49% 0.00% -7.70% -4.40% -104.22% 0.00% -123.27% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
49 -62 -105 18 -761 -2.80 -47 -42 -210 -43 -51
NOPAT Margin
2.97% -3.49% -6.99% 1.14% -49.80% -0.17% -3.22% -2.67% -10.71% -2.11% -2.77%
Net Nonoperating Expense Percent (NNEP)
0.00% -0.13% 0.28% 0.00% 15.24% 0.65% 1.46% 2.03% 16.47% 0.92% 1.58%
Return On Investment Capital (ROIC_SIMPLE)
- -1.06% - - - -0.06% -1.08% -0.83% -4.40% -0.91% -1.08%
Cost of Revenue to Revenue
65.74% 70.09% 70.51% 65.21% 67.60% 64.10% 70.76% 71.38% 77.31% 71.45% 70.26%
SG&A Expenses to Revenue
25.18% 24.93% 26.43% 24.90% 24.21% 23.37% 25.94% 23.35% 24.32% 21.25% 23.29%
R&D to Revenue
3.15% 3.17% 3.26% 3.17% 2.95% 2.91% 2.88% 2.73% 3.77% 3.50% 3.47%
Operating Expenses to Revenue
30.39% 34.90% 39.48% 33.21% 103.53% 36.14% 33.84% 32.42% 37.99% 31.56% 33.69%
Earnings before Interest and Taxes (EBIT)
64 -88 -150 25 -1,087 -4.00 -67 -60 -300 -61 -73
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
127 -26 -91 84 -1,028 93 -7.00 -3.00 -193 46 27
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.82 0.81 0.91 0.61 0.99 0.97 0.57 0.59 1.30 0.67 0.55
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.32 0.30 0.32 0.22 0.20 0.17 0.10 0.11 0.07 0.04 0.02
Price to Earnings (P/E)
14.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
6.85% 5.95% 5.70% 8.61% 9.63% 11.86% 18.12% 12.33% 11.30% 8.61% 7.75%
Earnings Yield
6.76% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.92 0.91 0.96 0.83 1.00 0.99 0.89 0.91 1.02 0.97 0.97
Enterprise Value to Revenue (EV/Rev)
0.79 0.73 0.79 0.69 0.67 0.66 0.61 0.71 0.70 0.61 0.57
Enterprise Value to EBITDA (EV/EBITDA)
12.10 22.68 0.00 47.76 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
26.81 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
30.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
11.60 7.37 10.00 8.06 7.78 8.02 7.58 11.95 12.61 19.02 25.19
Enterprise Value to Free Cash Flow (EV/FCFF)
14.86 7.14 7.89 6.04 4.70 7.43 7.78 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.19 1.18 1.39 1.28 2.14 2.61 2.57 2.92 7.42 6.31 8.40
Long-Term Debt to Equity
0.91 0.98 1.23 1.23 1.80 2.16 2.11 2.58 6.82 5.97 8.09
Financial Leverage
0.91 0.86 0.89 0.88 1.28 1.37 1.52 1.60 3.14 3.32 3.77
Leverage Ratio
3.36 3.39 3.34 3.23 4.12 4.51 4.68 4.66 8.65 9.20 10.01
Compound Leverage Factor
3.36 3.39 3.34 3.23 4.12 4.51 4.68 4.66 8.65 9.20 10.01
Debt to Total Capital
54.43% 54.17% 58.14% 56.06% 68.12% 72.27% 72.02% 74.48% 88.12% 86.32% 89.37%
Short-Term Debt to Total Capital
13.12% 9.37% 6.53% 2.19% 10.81% 12.44% 13.08% 8.65% 7.08% 4.70% 3.32%
Long-Term Debt to Total Capital
41.31% 44.80% 51.61% 53.87% 57.31% 59.83% 58.94% 65.82% 81.04% 81.63% 86.05%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.51% 3.87% 3.50% 3.87% 4.75% 4.85% 4.98% 4.33% 4.58% 4.65% 4.62%
Common Equity to Total Capital
42.06% 41.96% 38.36% 40.07% 27.13% 22.88% 23.00% 21.20% 7.30% 9.02% 6.01%
Debt to EBITDA
7.79 14.70 -212.00 35.14 -3.08 -3.61 -3.84 -4.17 -40.05 -27.05 -36.15
Net Debt to EBITDA
6.65 12.37 -171.71 29.98 -2.59 -3.00 -3.45 -3.70 -35.70 -23.79 -31.39
Long-Term Debt to EBITDA
5.92 12.15 -188.18 33.77 -2.59 -2.99 -3.15 -3.69 -36.84 -25.58 -34.80
Debt to NOPAT
19.61 -167.19 -19.58 -31.67 -3.59 -3.99 -4.16 -4.62 -14.60 -12.43 -12.86
Net Debt to NOPAT
16.72 -140.71 -15.86 -27.02 -3.02 -3.32 -3.73 -4.10 -13.02 -10.93 -11.17
Long-Term Debt to NOPAT
14.89 -138.27 -17.38 -30.43 -3.02 -3.31 -3.40 -4.09 -13.43 -11.76 -12.38
Altman Z-Score
1.60 1.57 1.59 1.66 1.14 1.46 1.39 1.40 0.98 1.10 1.13
Noncontrolling Interest Sharing Ratio
7.20% 7.37% 7.14% 7.41% 10.13% 11.33% 11.48% 11.60% 21.51% 23.12% 25.30%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.12 1.14 1.37 1.49 1.26 1.12 1.09 1.46 1.10 1.11 1.18
Quick Ratio
0.80 0.82 0.98 1.03 0.86 0.77 0.67 0.80 0.67 0.68 0.73
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
242 666 750 866 1,057 1,400 1,234 521 -450 -324 -198
Operating Cash Flow to CapEx
1,033.33% 3,890.00% -790.00% 1,537.50% 1,288.89% 2,064.71% -445.00% -57.89% 414.29% 866.67% -685.71%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.65 0.64 0.64 0.65 0.68 0.68 0.68 0.67 0.72 0.77 0.82
Accounts Receivable Turnover
8.24 8.07 8.02 7.43 7.49 7.56 7.42 7.23 6.55 7.32 7.28
Inventory Turnover
6.01 6.27 5.47 5.64 5.79 6.13 5.25 5.22 4.99 5.99 5.73
Fixed Asset Turnover
24.02 23.50 24.00 25.58 25.59 24.07 28.07 29.83 20.27 21.91 25.87
Accounts Payable Turnover
4.03 3.85 3.73 4.33 4.39 4.02 3.81 4.16 3.94 4.06 4.04
Days Sales Outstanding (DSO)
44.32 45.24 45.51 49.16 48.71 48.29 49.20 50.52 55.71 49.85 50.16
Days Inventory Outstanding (DIO)
60.78 58.20 66.70 64.76 63.02 59.56 69.52 69.97 73.16 60.98 63.66
Days Payable Outstanding (DPO)
90.62 94.80 97.90 84.28 83.14 90.79 95.78 87.73 92.71 89.84 90.39
Cash Conversion Cycle (CCC)
14.48 8.64 14.31 29.63 28.60 17.06 22.93 32.76 36.16 20.98 23.43
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
6,099 5,530 5,524 5,407 4,281 4,127 4,243 4,844 4,521 4,408 4,390
Invested Capital Turnover
1.14 1.17 1.12 1.11 1.23 1.29 1.26 1.20 1.50 1.65 1.72
Increase / (Decrease) in Invested Capital
-193 -728 -855 -848 -1,818 -1,403 -1,281 -563 240 281 147
Enterprise Value (EV)
5,604 5,057 5,291 4,489 4,269 4,099 3,795 4,385 4,629 4,262 4,257
Market Capitalization
2,294 2,065 2,155 1,443 1,291 1,048 605 663 473 298 166
Book Value per Share
$17.75 $20.65 $19.15 $19.01 $10.48 $8.65 $8.41 $8.92 $2.90 $3.47 $2.32
Tangible Book Value per Share
($0.70) ($3.14) ($4.08) ($4.13) ($4.46) ($8.82) ($9.01) ($8.62) ($22.02) ($21.08) ($21.72)
Total Capital
6,631 6,049 6,199 5,892 4,802 4,703 4,579 5,293 5,000 4,920 4,975
Total Debt
3,609 3,277 3,604 3,303 3,271 3,399 3,298 3,942 4,406 4,247 4,446
Total Long-Term Debt
2,739 2,710 3,199 3,174 2,752 2,814 2,699 3,484 4,052 4,016 4,281
Net Debt
3,077 2,758 2,919 2,818 2,750 2,823 2,962 3,493 3,927 3,735 3,861
Capital Expenditures (CapEx)
12 10 10 8.00 9.00 17 20 19 28 24 21
Debt-free, Cash-free Net Working Capital (DFCFNWC)
686 446 630 649 616 325 491 1,126 229 65 158
Debt-free Net Working Capital (DFNWC)
1,218 965 1,315 1,134 1,137 901 827 1,575 708 577 743
Net Working Capital (NWC)
348 398 910 1,005 618 316 228 1,117 354 346 578
Net Nonoperating Expense (NNE)
0.00 -3.60 8.00 0.00 444 18 43 64 550 30 54
Net Nonoperating Obligations (NNO)
3,077 2,758 2,929 2,818 2,750 2,823 2,962 3,493 3,927 3,735 3,861
Total Depreciation and Amortization (D&A)
63 62 59 59 59 97 60 57 107 107 100
Debt-free, Cash-free Net Working Capital to Revenue
9.71% 6.48% 9.44% 9.99% 9.67% 5.22% 7.95% 18.24% 3.47% 0.93% 2.13%
Debt-free Net Working Capital to Revenue
17.25% 14.01% 19.71% 17.45% 17.84% 14.48% 13.39% 25.51% 10.72% 8.22% 10.03%
Net Working Capital to Revenue
4.93% 5.78% 13.64% 15.47% 9.70% 5.08% 3.69% 18.09% 5.36% 4.93% 7.80%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.29 ($0.40) ($0.94) $0.12 ($9.71) ($0.22) ($0.75) ($0.87) ($6.01) ($0.62) ($0.84)
Adjusted Weighted Average Basic Shares Outstanding
122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M 125.83M 128.04M 128.62M 130.78M
Adjusted Diluted Earnings per Share
$0.28 ($0.39) ($0.94) $0.11 ($9.71) ($0.21) ($0.75) ($0.87) ($6.01) ($0.62) ($0.84)
Adjusted Weighted Average Diluted Shares Outstanding
122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M 125.83M 128.04M 128.62M 130.78M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M 125.83M 128.04M 128.62M 130.78M
Normalized Net Operating Profit after Tax (NOPAT)
57 31 -78 27 19 0.70 -48 -35 -169 -44 -20
Normalized NOPAT Margin
3.43% 1.75% -5.17% 1.69% 1.24% 0.04% -3.27% -2.22% -8.60% -2.17% -1.06%
Pre Tax Income Margin
3.87% -4.99% -9.99% 1.58% -71.14% -0.25% -4.60% -3.81% -15.30% -3.01% -3.95%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
96.13% 16,500.00% -85.79% -142.31% -10.38% -10.67% -11.02% -9.00% -10.13% -6.90% -4.02%
Augmented Payout Ratio
396.69% 70,900.00% -384.70% -668.27% -10.60% -11.28% -11.40% -9.35% -10.64% -6.90% -4.02%

Financials Breakdown Chart

Key Financial Trends

Xerox’s latest quarter shows a mixed picture: revenue held up better than profits, but profitability and balance sheet leverage remain major concerns. In Q1 2026, revenue was $1.846 billion, up from $1.613 billion in Q4 2025 and $1.457 billion in Q1 2025, but the company still posted a net loss of $105 million. The quarter also included a $45 million restructuring charge, which helped push operating income deeper into negative territory.

Revenue trends have improved from the weak stretch seen in late 2024 and early 2025. Q1 2026 revenue increased year over year from $1.457 billion to $1.846 billion, and gross profit rose to $549 million from $426 million a year earlier. That said, Xerox’s cost structure is still heavy, and operating expenses exceeded gross profit again, resulting in an operating loss of $73 million.

Margins remain under pressure despite better top-line performance. In Q1 2026, gross margin was about 29.7% ($549 million gross profit on $1.846 billion revenue), but operating expenses totaled $622 million. SG&A alone was $430 million, while restructuring, amortization, and other operating expenses added further drag. This suggests Xerox still has limited room to convert sales growth into meaningful earnings growth.

Cash flow improved sequentially, but operating cash generation is still uneven. Xerox used $144 million in operating cash in Q1 2026, compared with positive operating cash flow of $208 million in Q4 2025. For the full recent trend, operating cash generation has swung sharply quarter to quarter, which makes it harder to rely on the company’s cash-producing ability.

The balance sheet is highly leveraged, with negative tangible equity dynamics still a concern. As of Q1 2026, total debt stood at $4.446 billion combined between short-term and long-term debt, while total liabilities were $9.373 billion versus only $305 million of equity including noncontrolling interests. That level of leverage leaves Xerox sensitive to earnings volatility and refinancing risk.

Liquidity looks better than equity levels suggest, but debt remains manageable only if operations stabilize. Xerox held $585 million in cash and equivalents at the end of Q1 2026, up from $336 million in Q1 2025. Current assets of $3.78 billion exceeded current liabilities of $3.022 billion, so near-term liquidity is not the most immediate issue. The bigger question is whether the company can sustain cash generation while servicing debt.

Longer-term trends show significant deterioration from the stronger 2022 and early 2023 periods. Xerox was profitable in several quarters in 2022 and early 2023, including Q4 2022 and Q1 2023, but results weakened materially afterward. A notable turning point was Q3 2024, when the company reported a massive impairment charge and a very large operating loss, underscoring how volatile reported earnings can be.

  • Revenue in Q1 2026 rebounded to $1.846 billion, above the prior-year quarter.
  • Gross profit improved to $549 million from $426 million a year earlier.
  • Cash and equivalents rose to $585 million, improving short-term liquidity.
  • Current assets of $3.78 billion exceeded current liabilities of $3.02 billion.
  • Q1 2026 operating cash flow was negative $144 million, but cash flow has been volatile across recent quarters.
  • The company continues to return small amounts of cash to shareholders through dividends.
  • Xerox reported a Q1 2026 net loss of $105 million, or $(0.84) per share.
  • Operating income was negative $73 million, showing the core business is still not consistently profitable.
  • Debt remains elevated at $4.446 billion, with only $305 million in total equity including noncontrolling interests.
  • Restructuring and other operating charges continue to weigh on earnings and margins.

Bottom line: Xerox is showing some revenue stabilization and better liquidity, but profitability is still weak and leverage is high. For retail investors, the stock likely depends on whether management can turn improving sales into sustained positive operating income and free cash flow.

07/03/26 11:12 AM ETAI Generated. May Contain Errors.

Xerox Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Xerox's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Xerox's net income appears to be on an upward trend, with a most recent value of -$1.03 billion in 2025, falling from $207 million in 2017. The previous period was -$1.32 billion in 2024. Check out Xerox's forecast to explore projected trends and price targets.

Xerox's total operating income in 2025 was -$488 million, based on the following breakdown:
  • Total Gross Profit: $1.90 billion
  • Total Operating Expenses: $2.39 billion

Over the last 8 years, Xerox's total revenue changed from $9.99 billion in 2017 to $7.02 billion in 2025, a change of -29.7%.

Xerox's total liabilities were at $9.15 billion at the end of 2025, a 29.6% increase from 2024, and a 52.4% decrease since 2018.

In the past 7 years, Xerox's cash and equivalents has ranged from $512 million in 2025 to $5.48 billion in 2019, and is currently $512 million as of their latest financial filing in 2025.

Over the last 8 years, Xerox's book value per share changed from 0.00 in 2017 to 3.47 in 2025, a change of 346.8%.



Financial statements for NASDAQ:XRX last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners